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Downregulation of RhoGDIα increased migration and invasion of ER+ MCF7 and ER− 
MDA-MB-231 breast cancer cells. 
 
ABSTRACT 
Rho GDp dissociation inhibitors (RhoGDIs) can inhibit cell motility, invasion, and metastasis 
in cancer by inactivating the RhoGTpases. A member of RhoGDI family has been 
consistently shown to interact with estrogen receptor (eR), and change its transcriptional 
activity. eR is a receptor known to be inversely correlated with cell motility and invasion in 
breast cancer. The consequence of RhoGDIα activity on migration and invasion of eR+ and 
eR− breast cancers is not clear. The aim of our study was to investigate the possible opposing 
effect of RhoGDIα on the migration and invasion of eR+ MCF7 and eR− MDA-MB-231 
breast cancer cells. RhoGDIα was downregulated using short interfering RNA (siRNA) and 
upregulated using GFp-tagged ORF clone of RhoGDIα, and their ability for migration and 
invasion was assayed using transwell chambers. It was found that the silencing of RhoGDIα 
in MCF7 and MDA-MB-231 cells significantly increased migration and invasion of these 
cells into the lower surface of porous membrane of the chambers. Overexpression of 
RhoGDIα in MCF7 cells suppressed their migration and invasion, but no significant effect 
was found on MDA-MB-231 cells. Our results indicate that the downregulation of RhoGDIα 
similarly affects the in vitro migration and invasion of eR+ MCF7 and eR− MDA-MB-231 
cells. however, our assays are differently affected by the upregulation of RhoGDIα in these 
two cell lines and this may be due to the differences in eR expression, primary invasive 
ability and/or other molecules between these two cell line models which warrant further 
investigation. 
  
Keyword: Invasion; MCF7; MDA-MB-231; Migration; Transwell. 
 
 
